AR026040A1 - Sistema terapeutico transdermal que contiene clorhidrato de tulobuterol para la administracion del broncodilatador tulobuterol a traves de la piel - Google Patents

Sistema terapeutico transdermal que contiene clorhidrato de tulobuterol para la administracion del broncodilatador tulobuterol a traves de la piel

Info

Publication number
AR026040A1
AR026040A1 ARP000105398A ARP000105398A AR026040A1 AR 026040 A1 AR026040 A1 AR 026040A1 AR P000105398 A ARP000105398 A AR P000105398A AR P000105398 A ARP000105398 A AR P000105398A AR 026040 A1 AR026040 A1 AR 026040A1
Authority
AR
Argentina
Prior art keywords
tulobuterol
therapeutic system
transdermal therapeutic
chlorhydrate
bronchodilator
Prior art date
Application number
ARP000105398A
Other languages
English (en)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of AR026040A1 publication Critical patent/AR026040A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Un sistema terapéutico transdermal que comprende una capa superior básicamente impermeable al vapor de agua, al menos una capa matriz que contiene comoprincipio activo tulobuterol, así como una capa protectora amovible, se caracteriza por estarforma da la matriz a base de adhesivos de contacto de poliacrilatoy contener tulobuterol en forma de su sal de clorhidrato de tulobuterol como principio activo.
ARP000105398A 1999-10-16 2000-10-13 Sistema terapeutico transdermal que contiene clorhidrato de tulobuterol para la administracion del broncodilatador tulobuterol a traves de la piel AR026040A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19950066A DE19950066A1 (de) 1999-10-16 1999-10-16 Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut

Publications (1)

Publication Number Publication Date
AR026040A1 true AR026040A1 (es) 2002-12-26

Family

ID=7925993

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000105398A AR026040A1 (es) 1999-10-16 2000-10-13 Sistema terapeutico transdermal que contiene clorhidrato de tulobuterol para la administracion del broncodilatador tulobuterol a traves de la piel

Country Status (12)

Country Link
US (1) US7056528B1 (es)
EP (1) EP1220662B1 (es)
JP (2) JP4874486B2 (es)
KR (1) KR101014074B1 (es)
AR (1) AR026040A1 (es)
AT (1) ATE299019T1 (es)
AU (1) AU7662400A (es)
CA (1) CA2387143C (es)
DE (2) DE19950066A1 (es)
ES (1) ES2245648T3 (es)
PT (1) PT1220662E (es)
WO (1) WO2001028531A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100469995B1 (ko) * 2002-05-20 2005-02-05 안국약품 주식회사 천식치료제를 함유한 매트릭스형 패취
US8029820B2 (en) * 2003-06-20 2011-10-04 Teikoku Seiyaku Co., Ltd. Patches containing tulobuterol
CA2542778C (en) * 2003-10-28 2012-05-29 Noven Pharmaceuticals, Inc. Transdermal drug delivery composition
CN1297257C (zh) * 2004-01-02 2007-01-31 上海现代药物制剂工程研究中心有限公司 含有妥洛特罗的压敏胶，透皮贴剂及制备方法和应用
JP4919807B2 (ja) * 2004-11-10 2012-04-18 久光製薬株式会社 外用製剤及び貼付剤
JP5025268B2 (ja) * 2004-11-10 2012-09-12 久光製薬株式会社 外用製剤及び貼付剤
US8080560B2 (en) * 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
DE102004062614B4 (de) * 2004-12-24 2011-12-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit aktivierbarer Übersättigung und kontrollierter Permeationförderung sowie Verfahren zu dessen Herstellung
WO2010141587A1 (en) * 2009-06-05 2010-12-09 Megtec Systems, Inc. Improved infrared float bar
JP5766475B2 (ja) * 2010-03-30 2015-08-19 日東電工株式会社 貼付製剤およびその製造方法
KR101853082B1 (ko) * 2011-03-24 2018-04-27 테이코쿠 팔마 유에스에이, 인코포레이티드 활성제층 및 활성제 변환층을 포함하는 경피 조성물
KR101938919B1 (ko) * 2011-07-21 2019-01-15 데이고꾸세이약꾸가부시끼가이샤 수성 첩부제
CN102552221B (zh) * 2012-01-11 2013-09-04 中国人民解放军军事医学科学院微生物流行病研究所 一种妥洛特罗贴剂及其制备方法
AP2014007862A0 (en) 2012-01-11 2014-08-31 Adelaide Res & Innovation Pty Stabilising and analysing fatty acids in a biological sample stored on solid media
NZ706590A (en) 2012-11-02 2016-02-26 Teikoku Pharma Usa Inc Propynylaminoindan transdermal compositions
WO2016059583A1 (en) * 2014-10-17 2016-04-21 Fidia Farmaceutici S.P.A. Dermal therapeutic system with high adhesivity
TW201946617A (zh) 2017-04-28 2019-12-16 日商日東電工股份有限公司 經皮吸收製劑
CN109541065B (zh) * 2018-12-04 2019-10-01 山东大学 一种妥洛特罗贴剂的分析方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU578275B2 (en) * 1984-03-01 1988-10-20 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Pharmaceutical compositions
JPH0725669B2 (ja) 1988-12-23 1995-03-22 日東電工株式会社 経皮投与用医薬製剤
DE4002281A1 (de) * 1990-01-26 1991-08-01 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit dem wirkstoff tulobuterol
IT1251469B (it) 1991-07-15 1995-05-15 Zambon Spa Sistema terapeutico transdermale per la somministrazione di farmaci ad attivita' broncodilatante.
EP0593807A1 (en) * 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH & Co. KG Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
WO1994002119A1 (en) * 1992-07-23 1994-02-03 Hisamitsu Pharmaceutical Co., Inc. Percutaneously administrable base composition and drug composition prepared therefrom
JP2753800B2 (ja) * 1994-04-14 1998-05-20 日東電工株式会社 経皮吸収型製剤
JP3466305B2 (ja) * 1994-12-12 2003-11-10 久光製薬株式会社 溶解剤および該溶解剤を含有する外用製剤
CN1232389A (zh) * 1996-10-04 1999-10-20 崎玉第一制药株式会社 贴剂
DE19653605C2 (de) * 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
IT1294748B1 (it) * 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
JP3930984B2 (ja) * 1997-12-12 2007-06-13 日東電工株式会社 経皮吸収型製剤
US6375963B1 (en) * 1999-06-16 2002-04-23 Michael A. Repka Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof

Also Published As

Publication number Publication date
JP4874486B2 (ja) 2012-02-15
WO2001028531A1 (de) 2001-04-26
KR101014074B1 (ko) 2011-02-14
PT1220662E (pt) 2005-10-31
EP1220662A1 (de) 2002-07-10
KR20020047240A (ko) 2002-06-21
EP1220662B1 (de) 2005-07-06
AU7662400A (en) 2001-04-30
ES2245648T3 (es) 2006-01-16
JP2011252003A (ja) 2011-12-15
CA2387143C (en) 2009-06-02
JP2003528037A (ja) 2003-09-24
CA2387143A1 (en) 2001-04-26
DE50010679D1 (de) 2005-08-11
ATE299019T1 (de) 2005-07-15
US7056528B1 (en) 2006-06-06
DE19950066A1 (de) 2001-04-26

Similar Documents

Publication Publication Date Title
AR026040A1 (es) Sistema terapeutico transdermal que contiene clorhidrato de tulobuterol para la administracion del broncodilatador tulobuterol a traves de la piel
AR064268A1 (es) Sistema terapeutico transdermico para administracion del principio activo buprenorfina
AR093940A1 (es) Sistema de liberacion transdermica, metodo de preparacion
DE60018797D1 (de) Hydroxide freisetzende verbindungen zum verbessern der hautdurchlässigkeit
AR012790A1 (es) Un articulo absorbente para absorcion de fluidos corporales y metodo para ayudar a mantener la piel de un usuario a un ph acido.
AR046307A1 (es) Metodo de pretratamiento y sistema para mejorar la administracion transdermica de drogas
ES2176234T3 (es) Sistema terapeutico transdermal con galantamina como componente activo.
CO5640120A2 (es) Formulacion y metodods para el tratamiento de trombocitemia
HK1069534A1 (es)
PT1524975E (pt) Sistema aperfeicoado de administracao transdermica para a administracao de rotigotina
AR090677A2 (es) Preparacion farmaceutica que contiene oxicodona y naloxona
HUP0203623A2 (hu) Tramadol-szacharinátot tartalmazó, késleltetett hatású adagolási forma és alkalmazása
AR002262A1 (es) Composicion y metodo para el tratamiento de enfermedades fungales de las unas y un vendaje adaptado para la administracion topica de medicacion a lasunas.
AR029716A1 (es) Productos dermatologicos en forma de hoja
AR055552A1 (es) Preparacion topica refrescante para parches y metodos para utilizar la misma
AR039164A1 (es) Sales de venlafaxina de baja solubilidad en agua
NZ541807A (en) UV stable transdermal therapeutic plaster
DK1418894T3 (da) Transdermalt terapeutisk system med fentanyl
AR063782A1 (es) Parche y metodo transdermico para emesis
AR028525A1 (es) Sistema terapeutico transdermal para la administracion de lerisetron
CL2010000524A1 (es) Uso de una composición tópica que comprende 3,75% de imiquimod y un portador farmacéuticamente aceptable para preparar un medicamento útil para tratar verrugas genitales o perianales.
AR026038A1 (es) Sistema terapeutico transdermal para la administracion de acido acetilsalicilico y/o acido salicilico y proceso de fabricacion
NZ509215A (en) Transdermal plaster preparation containing at least one active ingredient which influences blood serum lipid levels
GT200300249A (es) Administracion dermica de un inhibidor de ciclooxigenasa-2 selectivo soluble en agua
NZ584190A (en) Once-a-day replacement transdermal administration of fentanyl